ClinicalTrials.gov
public full text
Public Domain
Cangrelor to Clopidogrel or Prasugrel Transition Study
There are two separate objectives in this study: 1. To demonstrate the pharmacodynamic (PD) profile when participants treated with cangrelor are switched to oral prasugrel 60 mg administered 30 minutes (min) after cangrelor infusion is discontinued 2. To demonstrate the PD profile when participants treated with cangrelor are switched to oral clopidogrel 600 mg administered during or immediately after cangrelor infusion.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy#1088480
- Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function: a Validation Study#1211996
- The Bridging Antiplatelet Therapy With Cangrelor 2 Study#1262700
- Effect of Prasugrel Versus Clopidogrel on Platelet Function After Bivalirudin Cessation#1033103
- Safety of Continuing Anti-platelet Agents During Colonoscopic Polypectomy: A Prospective Study#1162894
Record · ID 1349893
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive